In this article
Many processed foods are now filled with highly refined soluble fiber, such as inulin, which is a popular probiotic, recently approved by the US Food and Drug Administration. But a new study from the School of Medicine and Life Sciences at the University of Toledo raises a serious question as to whether the risks of processing refined fibers into processed foods will greatly exceed the benefits.
Dr. Matam Vijay-Kumar, director of the UT Microbiology Organization Alliance and associate professor of the Department of UT Physiology and Pharmacology, and his team recently investigated whether a diet rich in refined inulin can help combat obesity-related complications in mice. Although a diet containing inulin did avoid obesity in 40% of mice, many mice developed liver cancer at the end of the 6-month study. Vijay-Kumar said, "At the same time, we accepted the challenge of exploring how processing dietary soluble fiber can induce liver cancer."
Although this study was conducted on mice, it has potential implications for human health. Researchers say that processed foods containing refined fermentable fibers should be handled very carefully. Fiber in whole foods such as fruits and vegetables is healthy, and it sounds logical to strengthen or add purified fiber to processed foods. However, the results indicate that it may be dangerous. The results of this study were published in Cell on October 18
There are two basic types of natural dietary fiber, soluble and insoluble. Although both types are beneficial, the questions raised in the study involve how the intestinal bacteria break down the highly refined fiber added to processed food as a dietary supplement. Dr. Vishal Singh, a researcher at the Crohn's Disease and Colitis Foundation at the University of Toledo and the first author of the paper, said that refined fiber is a new member of our diet and we are in the early stages of understanding the risks and benefits. The soluble fiber added to processed food is not part of the natural diet, and during the extraction and processing of fiber, it undergoes a chemical process. In this study, mice with liver cancer showed changed and increased intestinal bacteria, a condition called dysbiosis. The researchers did not observe evidence of liver cancer in mice fed inulin that were treated with broad-spectrum antibiotics to consume gut bacteria.
UT researchers collaborated with researchers at Georgia State University, and they conducted similar studies in sterile mice completely free of intestinal bacteria. The absence of liver cancer in these mice further confirmed that intestinal bacteria degraded and digested soluble fibers through fermentation. To suppress this fermentation process, UT researchers fed mice beta acid from Humulus lupulus, a plant commonly used to produce hops that enter beer to prevent spoilage and fermentation. Feeding beta-acids to inulin-fed mice was able to avoid liver cancer, again confirming the link between bacterial fermentation of soluble fibers and the development of liver cancer. The researchers concluded that more research is needed on human consumption of refined fiber types in processed foods, as abnormal fermentation of this fiber may increase liver cancer risk, particularly for individuals with excessive gut bacteria growth or dysbiosis.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

About Dr. Nishant Mittal
Dr. Nishant Mittal is a highly accomplished researcher with over 13 years of experience in the fields of cardiovascular biology and cancer research. Significant contributions to stem cell biology, developmental biology, and innovative research techniques mark his career. Research Highlights Dr. Mittal's research has focused on several key areas: 1) Cardio…
✓ Reviewed for medical accuracy by the CancerFax review panel.
Medical Disclaimer
This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.
Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.
